Clinical Trial Update: Phase I Trial of Clofarabine in Combo w/ HD Etoposide & Cyclophosphamide and APBSCT for Pts w/ High-Risk or Refractory NHL [Phase 1]

View source ↗

Summary

Phase I trial of Clofarabine with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplant for high-risk or refractory non-Hodgkin l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Clolar (Clofarabine)
• Etoposide (Etoposide)

Snippet

Sponsor: Indiana University School of Medicine | Conditions: Non Hodgkin's Lymphoma | Phase 1 | Status: COMPLETED